<DOC>
	<DOCNO>NCT01283724</DOCNO>
	<brief_summary>A clinical trial design demonstrate safety efficacy Visanne ( approve endometriosis adult ) adolescent population .</brief_summary>
	<brief_title>Visanne Study Assess Safety Adolescents</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<criteria>Female adolescent menarche ( 12 less 18 year age ) screening . For Finland : Adolescents age 12 14 year old present clinical feature endometriosis enrol study diagnosis endometriosis confirm laparoscopy . Dysmenorrhea least moderate intensity , without chronic pelvic pain , least 2 cycle previous 4 month one follow condition : Clinically suspect endometriosis base presence pelvic pain incompletely relieve non steroidal antiinflammatory drug and/or oral contraceptive Any abdominal pain associate ultrasound finding suggestive endometriosis ( abdominal , vaginal rectal ; additional specific consent assent ) Failure surgical treatment endometriosis ( cyclic chronic pelvic pain least 4 month duration postsurgery ) Threshold endometriosisassociated pelvic pain ( EAPP ) score : least 30 100 unit visual analog scale retrospectively evaluate screen last 4 week Absence endometriosis laparoscopy Previous application hormonal agent include oral contraceptive within 2 month , progestin , danazol within 3 month , Gonadotropin Releasing Hormone ( GnRH ) agonists within 6 month prior start treatment Chronic pelvic pain might relate genitourinary disease chronic recurrent gastrointestinal disease , include irritable bowel syndrome ( defined disease characterize pain relieved defecation irregular defecation pattern last least 3 month ) Clinically establish need primary surgical treatment endometriosis</criteria>
	<gender>Female</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Endometriosis</keyword>
	<keyword>DEXA</keyword>
	<keyword>Adolescent</keyword>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
	<keyword>Post-menarche</keyword>
</DOC>